CRRTF News and Press, Coronet Carpets Inc From 12/15/21

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“ Crescita ” or the “ Company ”) announced today that the Toronto Stock Exchange (the “ TSX ”) has approved the Company’s renewal of its existing normal course issuer bid ...

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita”), a growth-oriented, innovation-driven Canadian commercial dermatology company, is pleased to announce that it has signed an exclusive commercialization and supply agreement with Egis Pharmaceuticals PLC (...

- Pliaglis ® Licensed in 15 New Countries - Minority Interest Acquisition of 6 Medical Aesthetic Clinics in Ontario - Deployment of Capital to Support Growth in Medical Aesthetics Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita ...

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“Crescita”), a growth-oriented, innovation-driven Canadian commercial dermatology company, is pleased to announce that it has entered into a distribution agreement with Obagi Cosmeceuticals LLC (“Obagi”) ...

Enables Crescita to Participate in the Growing Medical Aesthetics Market Provides Commercial Platform for Crescita’s Medical and Aesthetic Brands Provides Insights into Consumer Preferences Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRR...

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“Crescita”), a growth-oriented, innovation-driven Canadian commercial dermatology company, and STADA MENA DWC-LLC (“STADA”), a subsidiary of STADA Arzneimittel AG, a specialty pharma, generics and con...

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has entered into an exclusive commercialization and development licens...

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting results from its 2021 Annual General and Special Meeting of Shareho...

Positive Adjusted EBITDA 1 and Strong Liquidity Position Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its fi...

The following slide deck was published by Crescita Therapeutics Inc. in conjunction with this event. For further details see: Crescita Therapeutics (CRRTF) Investor Presentation - Slideshow